Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor
about
Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophagesHIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathwayRole of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant EnzymesThe roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunctionMicroarray analysis of cultured rat hippocampal neurons treated with brain derived neurotrophic factorMatrix metalloproteinase expression correlates with virulence following neurotropic mouse hepatitis virus infectionPhase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma.Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.Effect of cocaine on human immunodeficiency virus-mediated pulmonary endothelial and smooth muscle dysfunction.Fibroblast Growth Factor-2 and the HIV-1 Tat Protein Synergize in Promoting Bcl-2 Expression and Preventing Endothelial Cell Apoptosis: Implications for the Pathogenesis of AIDS-Associated Kaposi's Sarcoma.Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera.Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivoIdentification of putative biomarkers for HIV-associated neurocognitive impairment in the CSF of HIV-infected patients under cART therapy determined by mass spectrometry.Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases.Antitumour effects of antiretroviral therapy.Differences in NMDA receptor expression during human development determine the response of neurons to HIV-tat-mediated neurotoxicityHIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stressKaposi's sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherinVessel microport technique for applications in cerebrovascular research.Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia.Wound healing fibroblasts modulate corneal angiogenic privilege: interplay of basic fibroblast growth factor and matrix metalloproteinases in corneal angiogenesis.Pharmacological management of Kaposi's sarcoma.HIV/AIDS patients with HIV vasculopathy and VZV vasculitis: a case series.Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway.Endothelial stimulation by small lymphocytic lymphoma correlates with secreted levels of basic fibroblastic growth factor.AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo.Matrix metalloproteinases in the progression and regression of Kaposi's sarcoma.Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium.Matrix metalloproteinases 2 and 9, and extracellular matrix in Kaposi's sarcoma.Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications.Serum levels of metalloproteinases and their inhibitors during infection with pathogens having integrin receptor-mediated cellular entry.
P2860
Q21135536-DD1931CE-0A76-46BC-9F00-0547D7343FC1Q24541552-8BA39297-8097-413B-8A39-8377800D0C71Q26829535-7393188E-4D7D-420B-B514-FA4B9AFF9DACQ28386344-13198A37-83D9-42B0-8CF8-EE5149642A0CQ28571356-B09581A5-9C39-4735-8F3D-C45CBC2DCF6FQ34343357-FA6FB8C3-639C-4C37-910E-162D2CA2C1CBQ34472886-E2955231-15BB-4F7E-82F2-A0E5031B5BB2Q34587349-B1F9A327-25BB-487C-8271-D83C6457D9C6Q35026060-16316B87-5307-41EC-A8CE-4B0615B9B411Q35132178-F0AD7B30-18DE-44D9-AC2F-EC6E55E5AD74Q35294664-BFBAFAA4-D214-43E1-A941-8E68BF3B3CB0Q35540731-78A15733-5D27-4FDC-B002-33CCB7506F0BQ35662667-C33058C3-FFDF-469E-8492-C663C08E5AA7Q35791718-44DF9942-BA9D-4A7B-B07F-3741823ECDE7Q35825108-85D90A95-32D2-4159-B726-B37F786FE6B6Q35914351-0FD3AD69-DAA5-49F2-B3B5-54BC0784491AQ35934144-59A748ED-AA71-47FF-967A-D24795863082Q36296748-9698F131-4045-4E65-B4E2-172181B77CF8Q36450103-546E3DB9-5A16-4ED6-A334-367E2DF72BDFQ36974720-A0FF5CC3-245A-4ADB-92CD-7B66A50AA418Q37270325-58F6AE99-F615-475A-992C-4E18979C2BECQ37287856-61ACF83F-53E9-4A53-A7B4-1F1E73F23C93Q37767623-3229DD38-C54B-4768-859F-D719F707A6DFQ37868566-611B5D4F-57A8-484D-A58F-37BEAA8E67EDQ39991623-8A880D14-A2D8-4102-A089-23D711E32BA6Q40486626-FE1A57A4-6467-420F-BD93-7F31262EDD65Q40602644-8F56981D-358B-4A8F-A4E7-A361C6F74D3FQ40606232-B71773DA-46DB-4EBC-B776-5966E3836381Q44053161-EDBEEAC7-EFF6-4057-BAA9-538A9B2934BAQ45397527-B5DE3E99-FC3B-4623-84A5-C8CAB58D6B85Q52600877-E06AA79C-4AEC-479A-B96B-1E20BDFBF2C0Q52623530-09535A1C-2A1C-4487-8C3B-BFC822818AA6Q54331555-B0F1B635-7720-4934-9500-AAE761BA5400
P2860
Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Activation of matrix-metallopr ...... basic fibroblast growth factor
@ast
Activation of matrix-metallopr ...... basic fibroblast growth factor
@en
type
label
Activation of matrix-metallopr ...... basic fibroblast growth factor
@ast
Activation of matrix-metallopr ...... basic fibroblast growth factor
@en
prefLabel
Activation of matrix-metallopr ...... basic fibroblast growth factor
@ast
Activation of matrix-metallopr ...... basic fibroblast growth factor
@en
P2093
P2860
P356
P1476
Activation of matrix-metallopr ...... basic fibroblast growth factor
@en
P2093
A Cereseto
C Palladino
G Barillari
I Bacigalupo
P2860
P304
P356
10.1091/MBC.12.10.2934
P577
2001-10-01T00:00:00Z